Raquel Petrilli

Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy

Josimar O. Eloy, Raquel Petrilli, José Fernando Topan et al. · Colloids and Surfaces B Biointerfaces · 2016 · 151 citations · Full text

Lipid Preparation, Nanomedicine, Breast Oncology +10

Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection

Raquel Petrilli, Josimar O. Eloy, Fabiano Pinto Saggioro et al. · Journal of Controlled Release · 2018 · 114 citations · Full text

Egfr-targeted Liposomes, Medicine, Subcutaneous Injection +6

Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy

Josimar O. Eloy, Raquel Petrilli, Deise L. Chesca et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 113 citations · Full text

Breast Oncology, Polymer-drug Conjugate, Medicine +9

Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models

Fabíola Silva Garcia Praça, Wanessa Silva Garcia Medina, Josimar O. Eloy et al. · European Journal of Pharmaceutical Sciences · 2017 · 102 citations · Full text

Tissue Engineering, Engineering, Medicine +13

EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells

Josimar O. Eloy, Amalia Ruiz, Felipe Tita de Lima et al. · Colloids and Surfaces B Biointerfaces · 2020 · 63 citations · Full text

Drug Targeting, Egfr-targeted Immunoliposomes, Tumor Targeting +2